Samsara BioCapital, L.P.

CIK 1699737 · last filed 2026-02-17

Samsara BioCapital, L.P. is a corporate insider who has filed 10 SEC Form 4 insider transactions across 5 companies since 2021. The most recent filing shows the insider bought $25.0M of KLRS on Feb 17, 2026. Across all open-market trades the lifetime net is +$91.8M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $192.6M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$192.58M

Companies

5

Total Filings

10

Lifetime Open-Market Net

$91.78M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
KLRS 10%+ Owner 1,979,847 $4.33 $8.57M $25.00M 1 2026-02-17
MLYS 10%+ Owner 5,674,916 $23.62 $134.04M $16.20M 1 2025-03-17
NGNE 10%+ Owner 1,717,127 $29.10 $49.97M $3.78M 1 2024-11-27
CARGO Therapeutics, Inc. (CRGX) Delisted 10%+ Owner 4,121,689 $4.47 $18.42M $30.00M 1 2023-11-16
LENZ Therapeutics, Inc. (GRPH) Delisted 10%+ Owner 8,459,314 $22.26 $188.30M $16.81M 6 2022-04-13

Recent Filings

10 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-02-17 KLRS Buy (P) +2,399,235 $25.00M EDGAR
2025-03-17 MLYS Buy (P) +1,200,000 $16.20M EDGAR
2024-11-27 NGNE Buy (P) +146,310 $3.78M EDGAR
2023-11-16 CARGO Therapeutics, Inc. (CRGX) Delisted Mixed +12,143,967 $30.00M EDGAR
2022-04-13 LENZ Therapeutics, Inc. (GRPH) Delisted Buy (P) +848,928 $3.46M EDGAR
2022-01-25 LENZ Therapeutics, Inc. (GRPH) Delisted Buy (P) +246,000 $2.20M EDGAR
2022-01-21 LENZ Therapeutics, Inc. (GRPH) Delisted Buy (P) +195,340 $1.78M EDGAR
2021-11-24 LENZ Therapeutics, Inc. (GRPH) Delisted Buy (P) +403,370 $4.09M EDGAR
2021-10-15 LENZ Therapeutics, Inc. (GRPH) Delisted Buy (P) +101,600 $1.34M EDGAR
2021-10-08 LENZ Therapeutics, Inc. (GRPH) Delisted Buy (P) +290,992 $3.94M EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.